211 related articles for article (PubMed ID: 37539459)
1. Best practices in assessing cardiac protein
Zou L; Zhang D; Ha CM; Wende AR; Chatham JC
Am J Physiol Heart Circ Physiol; 2023 Oct; 325(4):H601-H616. PubMed ID: 37539459
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
3. Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.
Tashima Y; Stanley P
J Biol Chem; 2014 Apr; 289(16):11132-11142. PubMed ID: 24573683
[TBL] [Abstract][Full Text] [Related]
4. Molecular Interrogation to Crack the Case of O-GlcNAc.
Estevez A; Zhu D; Blankenship C; Jiang J
Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
[TBL] [Abstract][Full Text] [Related]
5. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
[TBL] [Abstract][Full Text] [Related]
6. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
7. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Collins HE; Chatham JC
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
[TBL] [Abstract][Full Text] [Related]
9. Differential Detection of O-GlcNAcylated proteins in the heart using antibodies.
Narayanan B; Zahra F; Reeves RA; Aggarwal A; O'Meally RN; Henry RK; Craven M; Jacobson A; Cole RN; Kohr MJ; Umapathi P; Zachara NE
Anal Biochem; 2023 Oct; 678():115262. PubMed ID: 37507081
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
11. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
[TBL] [Abstract][Full Text] [Related]
12. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
13. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
Butkinaree C; Park K; Hart GW
Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc)-processing enzymes.
King DT; Males A; Davies GJ; Vocadlo DJ
Curr Opin Chem Biol; 2019 Dec; 53():131-144. PubMed ID: 31654859
[TBL] [Abstract][Full Text] [Related]
15. Targeting O-GlcNAcylation to develop novel therapeutics.
Zhu Y; Hart GW
Mol Aspects Med; 2021 Jun; 79():100885. PubMed ID: 32736806
[TBL] [Abstract][Full Text] [Related]
16. Feedback Regulation of
Lin CH; Liao CC; Chen MY; Chou TY
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
[TBL] [Abstract][Full Text] [Related]
17. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
[TBL] [Abstract][Full Text] [Related]
18. Role of
Chatham JC; Zhang J; Wende AR
Physiol Rev; 2021 Apr; 101(2):427-493. PubMed ID: 32730113
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity.
Narayanan B; Sinha P; Henry R; Reeves RA; Paolocci N; Kohr MJ; Zachara NE
J Biol Chem; 2023 Dec; 299(12):105447. PubMed ID: 37949223
[TBL] [Abstract][Full Text] [Related]
20. Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation.
Mitchell CW; Galan Bartual S; Ferenbach AT; Scavenius C; van Aalten DMF
Glycobiology; 2023 Dec; 33(12):1172-1181. PubMed ID: 37856504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
